Effects of avermectins on neurite outgrowth in differentiating mouse neuroblastoma N2a cells

Toxicology Letters

Volumn 192, Issue 2, 2010, Pages 206-211

  Sun, Ying Jian ^a   Long, Ding Xin ^b   Li, Wei ^b   Hou, Wei Yuan ^b   Wu, Yi Jun ^b   Shen, Jian Zhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

Abamectin; Cytoskeletal proteins; Differentiation; Doramectin; Neurotoxicity; P glycoprotein

Indexed keywords

ABAMECTIN; BETA ACTIN; BETA TUBULIN; CYTOSKELETON PROTEIN; DORAMECTIN; GLYCOPROTEIN P;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION PROCESS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; MOUSE; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING;

ACTINS; ANIMALS; ANTIPARASITIC AGENTS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; IVERMECTIN; MICE; NEURITES; NEUROBLASTOMA; NEURONS; NEUROTOXINS; P-GLYCOPROTEIN; TUBULIN;

EID: 74149084626     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.10.021     Document Type: Article

References (46)

1. Artho R., Schnyder M., Kohler L., Torgerson P.R., and Hertzberg H. Avermectin-resistance in gastrointestinal nematodes of Boer goats and Dorper sheep in Switzerland. Vet. Parasitol. 144 (2007) 68-73
2. Bates S.E., Mickley L.A., Chen Y.N., Richert N., Rudick J., Biedler J.L., and Fojo A.T. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation. Mol. Cell. Biol. 9 (1989) 4337-4344
3. Blackhall W.J., Prichard R.K., and Beech R.N. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 152 (2008) 101-107
4. Bourguinat C., Ardelli B.F., Pion S.D., Kamgno J., Gardon J., Duke B.O., Boussinesq M., and Prichard R.K. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 158 (2008) 101-111
5. Bowen J.M., and Vitayavirasak B. Contractile activity and motility responses of the dog heartworm Dirofilaria immitis to classical anthelmintics and other compounds. Vet. Parasitol. 134 (2005) 183-188
6. Brayden D.J., and Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Vet. Res. Commun. 32 (2008) 93-106
7. Campbell W.C., Fisher M.H., Stapley E.O., Albers-Schonberg G., and Jacob T.A. Ivermectin: a potent new antiparasitic agent. Science 221 (1983) 823-828
8. Chang P.A., and Wu Y.J. Effect of tri-o-cresyl phosphate on cytoskeleton in human neuroblastoma SK-N-SH cell. Mol. Cell. Biochem. 290 (2006) 145-151
9. Chen X.P., Wang Q., Guan J., Huang Z.Y., Zhang W.G., and Zhang B.X. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. World J. Gastroenterol 12 (2006) 3332-3337
10. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., and Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 695-698
11. Didier A., and Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs. 7 (1996) 745-751
12. Drinyaev V.A., Mosin V.A., Kruglyak E.B., Novik T.S., Sterlina T.S., Ermakova N.V., Kublik L.N., Levitman M., Shaposhnikova V.V., and Korystov Y.N. Antitumor effect of avermectins. Eur. J. Pharmacol. 501 (2004) 19-23
13. Eldefrawi A., and Eldefrawi M.E. Receptors for γ-aminobutyric acid and voltage-dependent chloride channels as targets for drugs and toxicants. FASEB J. 1 (1987) 262-271
14. Gan P.P., Pasquier E., and Kavallaris M. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Cancer Res. 67 (2007) 9356-9363
15. Geyer J., Döring B., Godoy J.R., Moritz A., and Petzinger E. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. J. Vet. Pharmacol. Ther. 28 (2005) 95-99
16. Goto M., Masuda S., Saito H., and Inui K. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2. Biochem. Pharmacol. 66 (2003) 163-170
17. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
18. Howell S.B., Burke J.M., Miller J.E., Terrill T.H., Valencia E., Williams M.J., Williamson L.H., Zajac A.M., and Kaplan R.M. Prevalence of anthelmintic resistance on sheep and goat farms in the southeastern United States. J. Am. Vet. Med. Assoc. 233 (2008) 1913-1919
19. Johnstone R.W., Ruefli A.A., and Smyth M.J. Multiple physiological functions for multidrug transporter P-glycoprotein?. Trends Biochem. Sci. 25 (2000) 1-6
20. Kavallaris M., Kuo D.Y., Burkhart C.A., Regl D.L., Norris M.D., Haber M., and Horwitz S.B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 100 (1997) 1282-1293
21. Kokoz Y.M., Tsyganova V.G., Korystova A.F., Grichenko A.S., Zenchenko K.I., Drinyaev V.A., Mosin V.A., Kruglyak E.B., Sterlina T.S., and Victorov A.V. Selective cytostatic and neurotoxic effects of avermectins and activation of the GABAalpha receptors. Biosci. Rep. 19 (1999) 535-546
22. Korystov Y.N., Ermakova N.V., Kublik L.N., Levitman M., Shaposhnikova V.V., Mosin V.A., Drinyaev V.A., Kruglyak E.B., Novik T.S., and Sterlina T.S. Avermectins inhibit multidrug resistance of tumor cells. Eur. J. Pharmacol. 493 (2004) 57-64
23. Lankas G.R., Cartwright M.E., and Umbenhauer D. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol. Appl. Pharmacol. 143 (1997) 357-365
24. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., and Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12 (1998) 457-463
25. Lawton M., Iqbal M., Kontovraki M., Lloyd Mills C., and Hargreaves A.J. Reduced tubulin tyrosination as an early marker of mercury toxicity in differentiating N2a cells. Toxicol. in Vitro 21 (2007) 1258-1261
26. Lee C.H., Bradley G., and Ling V. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo. J. Cell. Physiol. 177 (1998) 1-12
27. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., and Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 30 (2007) 84-94
28. Lim J.C., Wolpaw A.J., Caldwell M.A., Hladky S.B., and Barrand M.A. Neural precursor cell influences on blood-brain barrier characteristics in rat brain endothelial cells. Brain Res. 1159 (2007) 67-76
29. Lin T., Islam O., and Heese K. ABC transporters, neural stem cells and neurogenesis-a different perspective. Cell Res. 16 (2006) 857-871
30. Macdonald N., and Gledhill A. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans. Arch. Toxicol. 81 (2007) 553-563
31. Mhaidat N.M., Thorne R.F., de Bock C.E., Zhang X.D., and Hersey P. Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels. FEBS Lett. 582 (2008) 267-272
32. Payne G.T., and Soderlund D.M. Activation of gamma-aminobutyric acid insensitive chloride channels in mouse brain synaptic vesicles by avermectin B1a. J. Biochem. Toxicol. 6 (1991) 283-292
33. Portillo V., Jagannathan S., and Wolstenholme A.J. Distribution of glutamate-gated chloride channel subunits in the parasitic nematode Haemonchus contortus. J. Comp. Neurol. 462 (2003) 213-222
34. Prichard R.K. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?. Vet. Parasitol. 133 (2005) 243-253
35. Prichard R.K., and Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology 134 Pt. 8 (2007) 1123-1132
36. Roulet A., Puel O., Gesta S., Lepage J.F., Drag M., Soll M., Alvinerie M., and Pineau T. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur. J. Pharmacol. 460 (2003) 85-91
37. Sangster N.C., Bannan S.C., Weiss A.S., Nulf S.C., Klein R.D., and Geary T.G. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp. Parasitol. 91 (1999) 250-257
38. - channels by avermectin in rat cultured hippocampal neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 348 (1993) 628-632
39. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., and Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
40. Sharma R.K., and Netland P.A. Early born lineage of retinal neurons express class III beta-tubulin isotype. Brain Res. 1176 (2007) 11-17
41. Sidiropoulou E., Sachana M., Flaskos J., Harris W., Hargreaves A.J., and Woldehiwet Z. Diazinon oxon affects the differentiation of mouse N2a neuroblastoma cells. Arch. Toxicol. 83 (2009) 373-380
42. Siissalo S., Laitinen L., Koljonen M., Vellonen K.S., Kortejarvi H., Urtti A., Hirvonen J., and Kaukonen A.M. Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines. Eur. J. Pharm. Biopharm. 67 (2007) 548-554
43. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., and Schinkel A.H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104 (1999) 1441-1447
44. Umbenhauer D.R., Lankas G.R., Pippert T.R., Wise L.D., Cartwright M.E., Hall S.J., and Beare C.M. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol. 146 (1997) 88-94
45. Wise L.D., Allen H.L., Hoe C.M., Verbeke D.R., and Gerson R.J. Developmental neurotoxicity evaluation of the avermectin pesticide, emamectin benzoate, in Sprague-Dawley rats. Neurotoxicol. Teratol. 19 (1997) 315-326
46. Wolstenholme A.J., and Rogers A.T. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 131 (2005) S85